New Scientist, in association with SRG, is conducting a global salary, employment and industry survey (Life Sciences, Clinical & Engineering) to provide you with the latest insights into your salary. The results of this survey benchmarking salary will be published on the SRG website. Be part of the conversation and participate today!The questionnaire takes 5 - 10 minutes to complete and, as a thank you, all respondents who complete the survey will be entered into a prize draw to win one of three £150 Amazon vouchers (or local equivalent). The information you provide will only be used…
AMSBIO has expanded its range of high-performance magnetic beads for use as detection labels in magnetic immunoassays or as a solid support phase in immunoassays.
MagSi-STA beads are magnetic silica particles with high quality streptavidin covalently attached to the bead surface. Available in different mean sizes, streptavidin coupling chemistries and binding capacities, these industry-leading MagSi-STA beads offer an optimized solution for many in vitro diagnostic applications, including immunoassays.
To streamline the process of selecting the most suitable streptavidin beads for…
London, 18th December 2023 - Kadans Science Partner (“Kadans”) has added a new asset in King’s Cross, London, UK to its Pan-European portfolio. The new asset at 22-23 Tileyard Road will be delivered as purpose built, high-quality laboratory accommodation, providing much needed technical real estate to the King’s Cross and London market. The asset was acquired from City & Provincial Properties. This latest acquisition continues to grow Kadans’ footprint in the Knowledge Quarter, London, a global centre of excellence for science & technology innovation.
The Knowledge Quarter Kings…
Read the December eNews #lifescience newsletter featuring:✅ Welcome from Tony Jones, CEO✅ Upcoming Events and Important Dates for 2024!✅ Case Study: One Nucleus’ Facility Management for Constructive Bio✅ Congratulations to PrecisionLife and LifeArc, winners of the Genesis BioNewsRound Award 2023✅ Introducing ON Helix 2024 on 4 July in Cambridge
OXFORD, BRISTOL, EDINBURGH, UK – 15 December 2023 – Leading computational biology company PrecisionLife®, which is driving precision medicine in complex chronic diseases, the ME/CFS charity Action for M.E., and the MRC Human Genetics Unit at the Institute of Genetics and Cancer, University of Edinburgh have been awarded a £622,000 grant by Innovate UK's Advancing Precision Medicine programme to improve diagnosis and treatment for the millions of people affected by ME/CFS and long Covid.
ME/CFS and long Covid are debilitating conditions profoundly affecting the quality of life of over two…
We are excited to reach out to you, CEBR (Council of European BioRegion), network of health clusters from which your cluster is an active member, invites you to participate in a pivotal survey aimed at advancing the interests and growth of European health sector SMEs through internationalization.
About the Survey:
CEBR is at the forefront of an alliance of bio clusters dedicated to strengthening the health sector's internationalization. This survey is a cornerstone in our collective efforts to understand the unique challenges and requirements of SMEs in this dynamic…
As 2023 concludes, Biocair, an established global leader in life sciences logistics, proudly announces a year of remarkable achievements. With significant strides in sustainability, strategic partnerships and global expansion, Biocair affirms its commitment to being the specialist in temperature-controlled logistics for the life sciences industry.
Sustainability at the forefront:
In a landmark move towards its goal of becoming a net-zero business by 2040, Biocair introduced 100% electric vans to its Cambridge fleet in April. This step reflects Biocair's dedication to sustainable…
Cancer Research UK has appointed industry veteran Dr Lars Erwig as the new director for its Centre for Drug Development, the world's only charity-funded drug development facility.
With Cancer Research UK’s aim to beat cancer, the centre has a critical role to play in partnering with others to ensure that pre-clinical and early-phase clinical projects with the highest potential for patient benefit are prioritised and rapidly advanced.
In his new role, Dr Erwig will be responsible for shaping an exciting and cutting-edge portfolio of first-in-human trials for the charity, working closely…
Specialist Intellectual Property law firm Reddie & Grose is delighted to introduce its brand-new podcast series, ‘Talk IP with R&G’.
Hosted by experts from across the firm, the regular podcast is a go-to resource on how businesses can make the most of their intellectual property.
The first two episodes focus on using the Patent Box to lower your corporate tax bills; and on telling you everything you need to know about the Unified Patent Court, the most significant change to the European patent system in 50 years.
Subscribe and listen on Apple Podcasts or Spotify.
Pioneer Group, a company combining laboratory development and operation with venture building, is continuing its collaboration with Innovate UK by bringing its venture development ‘Launch Programme’ to the Exploit stage of Innovate UK’s ICURe programme.
The Launch Programme welcomes invited life science founders from the ICURe Programme, as well as the Pioneer Group ecosystem, to provide support in accelerating their development from lab to market adoption.
The ICURe programme is designed to help researchers explore the commercial application and potential of UK research. Building confidence…